CO6721048A2 - Anticuerpos que se unen a notum pectinacetilesterasa - Google Patents
Anticuerpos que se unen a notum pectinacetilesterasaInfo
- Publication number
- CO6721048A2 CO6721048A2 CO13149527A CO13149527A CO6721048A2 CO 6721048 A2 CO6721048 A2 CO 6721048A2 CO 13149527 A CO13149527 A CO 13149527A CO 13149527 A CO13149527 A CO 13149527A CO 6721048 A2 CO6721048 A2 CO 6721048A2
- Authority
- CO
- Colombia
- Prior art keywords
- antibodies
- pectinacetilesterase
- notum
- bind
- bind notum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
Se describen anticuerpos que neutralizan Notum pectinacetilesterasa, así como composiciones que los comprenden, y métodos de uso para tratar enfermedades y trastornos que afectan los huesos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41692710P | 2010-11-24 | 2010-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6721048A2 true CO6721048A2 (es) | 2013-07-31 |
Family
ID=46146184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13149527A CO6721048A2 (es) | 2010-11-24 | 2013-06-24 | Anticuerpos que se unen a notum pectinacetilesterasa |
Country Status (20)
Country | Link |
---|---|
US (3) | US20130302346A1 (es) |
EP (1) | EP2643019B1 (es) |
JP (1) | JP6033229B2 (es) |
KR (2) | KR20140026334A (es) |
CN (1) | CN103298490B (es) |
AU (1) | AU2011332007C1 (es) |
CA (1) | CA2817415C (es) |
CO (1) | CO6721048A2 (es) |
DK (1) | DK2643019T3 (es) |
ES (1) | ES2718849T3 (es) |
HU (1) | HUE043576T2 (es) |
IL (1) | IL225876A0 (es) |
MX (1) | MX357166B (es) |
NZ (1) | NZ609501A (es) |
PL (1) | PL2643019T3 (es) |
PT (1) | PT2643019T (es) |
RU (1) | RU2013123793A (es) |
SG (1) | SG189982A1 (es) |
WO (1) | WO2012071381A1 (es) |
ZA (1) | ZA201302983B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG187965A1 (en) * | 2010-08-27 | 2013-04-30 | Stem Centrx Inc | Notum protein modulators and methods of use |
ES2718849T3 (es) | 2010-11-24 | 2019-07-04 | Lexicon Pharmaceuticals Inc | Anticuerpos contra notum pectinacetilesterasa |
CA2858350A1 (en) | 2011-01-14 | 2013-07-19 | The Regents Of The University Of California | Therapeutic antibodies against ror-1 protein and methods for use of same |
US8802365B2 (en) * | 2011-03-22 | 2014-08-12 | Whitehead Institute For Biomedical Research | Methods for identifying candidate modulators of NOTUM activity |
CA2878712A1 (en) * | 2012-08-31 | 2014-03-06 | arGEN-X BV | Method for producing antibody molecules having inter-species, intra-target cross-reactivity |
WO2020150282A1 (en) * | 2019-01-18 | 2020-07-23 | Askgene Pharma Inc. | Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis |
CN110317271B (zh) * | 2019-07-02 | 2021-04-30 | 武汉云克隆科技股份有限公司 | 一种pinp重组抗体的重/轻链可变区及编码基因和重组抗体 |
EP4263613A1 (en) * | 2020-12-16 | 2023-10-25 | Memorial Sloan-Kettering Cancer Center | Cd40 binding molecules and uses thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
US4615885A (en) | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
ATE135370T1 (de) | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
JP3068180B2 (ja) | 1990-01-12 | 2000-07-24 | アブジェニックス インコーポレイテッド | 異種抗体の生成 |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
CA2288429C (en) | 1991-03-15 | 2006-04-25 | Synergen, Inc. | Pegylation of polypeptides |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
TW313568B (es) | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
US6127977A (en) | 1996-11-08 | 2000-10-03 | Cohen; Nathan | Microstrip patch antenna with fractal structure |
KR20080059467A (ko) | 1996-12-03 | 2008-06-27 | 아브게닉스, 인크. | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체 |
US6080576A (en) | 1998-03-27 | 2000-06-27 | Lexicon Genetics Incorporated | Vectors for gene trapping and gene activation |
GB0201808D0 (en) * | 2002-01-25 | 2002-03-13 | European Molecular Biology Lab Embl | Protein |
US20040063924A1 (en) * | 2002-01-28 | 2004-04-01 | Y Tom Tang | Secreted proteins |
EP1652923B1 (en) * | 2003-08-08 | 2011-10-12 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
SG187965A1 (en) * | 2010-08-27 | 2013-04-30 | Stem Centrx Inc | Notum protein modulators and methods of use |
ES2718849T3 (es) | 2010-11-24 | 2019-07-04 | Lexicon Pharmaceuticals Inc | Anticuerpos contra notum pectinacetilesterasa |
-
2011
- 2011-11-22 ES ES11843652T patent/ES2718849T3/es active Active
- 2011-11-22 US US13/885,815 patent/US20130302346A1/en not_active Abandoned
- 2011-11-22 NZ NZ609501A patent/NZ609501A/en unknown
- 2011-11-22 WO PCT/US2011/061785 patent/WO2012071381A1/en active Application Filing
- 2011-11-22 JP JP2013541012A patent/JP6033229B2/ja active Active
- 2011-11-22 AU AU2011332007A patent/AU2011332007C1/en active Active
- 2011-11-22 CA CA2817415A patent/CA2817415C/en active Active
- 2011-11-22 CN CN201180056452.6A patent/CN103298490B/zh active Active
- 2011-11-22 KR KR1020137013390A patent/KR20140026334A/ko not_active Application Discontinuation
- 2011-11-22 PT PT11843652T patent/PT2643019T/pt unknown
- 2011-11-22 MX MX2013005906A patent/MX357166B/es active IP Right Grant
- 2011-11-22 EP EP11843652.6A patent/EP2643019B1/en active Active
- 2011-11-22 KR KR1020187016214A patent/KR20180069083A/ko not_active Application Discontinuation
- 2011-11-22 PL PL11843652T patent/PL2643019T3/pl unknown
- 2011-11-22 SG SG2013031083A patent/SG189982A1/en unknown
- 2011-11-22 RU RU2013123793/10A patent/RU2013123793A/ru not_active Application Discontinuation
- 2011-11-22 DK DK11843652.6T patent/DK2643019T3/en active
- 2011-11-22 HU HUE11843652A patent/HUE043576T2/hu unknown
-
2013
- 2013-04-22 IL IL225876A patent/IL225876A0/en active IP Right Grant
- 2013-04-24 ZA ZA2013/02983A patent/ZA201302983B/en unknown
- 2013-06-24 CO CO13149527A patent/CO6721048A2/es not_active Application Discontinuation
-
2015
- 2015-11-25 US US14/952,264 patent/US20160152731A1/en not_active Abandoned
-
2019
- 2019-02-15 US US16/277,466 patent/US11059907B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20140026334A (ko) | 2014-03-05 |
MX357166B (es) | 2018-06-28 |
KR20180069083A (ko) | 2018-06-22 |
US20190241677A1 (en) | 2019-08-08 |
NZ609501A (en) | 2014-12-24 |
US20130302346A1 (en) | 2013-11-14 |
EP2643019B1 (en) | 2019-01-02 |
ZA201302983B (en) | 2017-06-28 |
IL225876A0 (en) | 2013-06-27 |
CN103298490B (zh) | 2017-04-26 |
EP2643019A1 (en) | 2013-10-02 |
ES2718849T3 (es) | 2019-07-04 |
HUE043576T2 (hu) | 2019-08-28 |
AU2011332007C1 (en) | 2017-03-02 |
JP2014501513A (ja) | 2014-01-23 |
US11059907B2 (en) | 2021-07-13 |
PT2643019T (pt) | 2019-04-23 |
SG189982A1 (en) | 2013-06-28 |
JP6033229B2 (ja) | 2016-11-30 |
CA2817415A1 (en) | 2012-05-31 |
AU2011332007A1 (en) | 2013-05-09 |
EP2643019A4 (en) | 2014-12-31 |
DK2643019T3 (en) | 2019-04-15 |
US20160152731A1 (en) | 2016-06-02 |
WO2012071381A1 (en) | 2012-05-31 |
BR112013012858A2 (pt) | 2018-09-04 |
CN103298490A (zh) | 2013-09-11 |
AU2011332007B2 (en) | 2016-11-10 |
MX2013005906A (es) | 2013-06-28 |
CA2817415C (en) | 2020-05-12 |
RU2013123793A (ru) | 2014-12-27 |
PL2643019T3 (pl) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6721048A2 (es) | Anticuerpos que se unen a notum pectinacetilesterasa | |
CL2012003385A1 (es) | Tratamiento para la incontinencia. | |
ECSP099502A (es) | 4-fenil-piran-3,5-dionas, 4-fenil-tiopiran-3,5-dionas y ciclohexantrionas como nuevos herbicidas | |
CL2016002877A1 (es) | Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos. | |
CR20140529A (es) | Anticuerpos e inmunoconjugados contra ly6e y métodos de uso | |
SV2010003593A (es) | Nuevos herbicidas | |
TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
ECSP14004976A (es) | Anticuerpos anti-il-36r | |
UY34210A (es) | Composiciones, métodos y sistemas para la micropropagación de plantas | |
GT201400063A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
CR20150047A (es) | Anticuerpos anti-cd22 e inmunoconjugados | |
BR112014019331A2 (pt) | anticorpos para cd47 e métodos de uso desses | |
CL2015002754A1 (es) | Método para descelularización de injertos de tejido | |
UY33627A (es) | Compuestos para tratar enfermedades neurodegenerativas | |
UY33917A (es) | ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?. | |
DOP2014000033A (es) | Aminoquinazolinas como inhibidores de quinasa | |
UY33931A (es) | Agentes de union biespecificos | |
AR090923A1 (es) | Anticuerpos anti-il-23 | |
UY35488A (es) | Xantinas sustituidas y métodos para su uso | |
NI201100208A (es) | Pirazinilpirazoles | |
BR112013032876A2 (pt) | uso de formulações, e, método para fertilizar plantas | |
BR112013007514A2 (pt) | anticorpo isolado, uso da composição e método | |
BR112015023074A2 (pt) | agentes de ligação-met e uso dos mesmos | |
UY33964A (es) | Métodos y composiciones para un mayor rendimiento de las plantas. | |
UY33976A (es) | Derivados de pirazolo-pirimidina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |